The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
Journal of Clinical Medicine · 09.05.2023 · 12 (10) · 3366
DOI: 10.3390/jcm12103366 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 09.05.2023. Verfasst von Niki L Reynaert und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, 6229 ER Maas…. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 390 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Lung Foundation, The Family Kamprad Foundation, The Swedish Heart and Lung Foundation.
Themen: COPD
Abstract (Originalsprache)
Chronic obstructive pulmonary disease (COPD) is a disease of the airways and lungs due to an enhanced inflammatory response, commonly caused by cigarette smoking. Patients with COPD are often multimorbid, as they commonly suffer from multiple chronic (inflammatory) conditions. This intensifies the burden of individual diseases, negatively affects quality of life, and complicates disease management. COPD and comorbidities share genetic and lifestyle-related risk factors and pathobiological mechanisms, including chronic inflammation and oxidative stress. The receptor for advanced glycation end products (RAGE) is an important driver of chronic inflammation. Advanced glycation end products (AGEs) are RAGE ligands that accumulate due to aging, inflammation, oxidative stress, and carbohydrate metabolism. AGEs cause further inflammation and oxidative stress through RAGE, but also through RAGE-independent mechanisms. This review describes the complexity of RAGE signaling and the causes of AGE accumulation, followed by a comprehensive overview of alterations reported on AGEs and RAGE in COPD and in important co-morbidities. Furthermore, it describes the mechanisms by which AGEs and RAGE contribute to the pathophysiology of individual disease conditions and how they execute crosstalk between organ systems. A section on therapeutic strategies that target AGEs and RAGE and could alleviate patients from multimorbid conditions using single therapeutics concludes this review.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, 6229 ER Maastricht, The Netherlands.
- COPD Center, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden.
- Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, 405 30 Gothenburg, Sweden.
- Department of Pathology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
ORCID-Profile: Lowie E G W Vanfleteren
Förderung
- Dutch Lung Foundation
- The Family Kamprad Foundation
- The Swedish Heart and Lung Foundation
- Swedish Government and Country Council
Zitieren
APA
Reynaert, N. L., Vanfleteren, L. E. G. W., & Perkins, T. N. (2023). The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD. Journal of Clinical Medicine, 12(10), 3366. https://doi.org/10.3390/jcm12103366
Vancouver
Reynaert NL, Vanfleteren LEGW, Perkins TN. The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD. Journal of Clinical Medicine. 2023;12(10):3366. doi:10.3390/jcm12103366
BibTeX
@article{Reynaert2023,
author = {Reynaert, Niki L and Vanfleteren, Lowie E G W and Perkins, Timothy N},
title = {The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {10},
pages = {3366},
doi = {10.3390/jcm12103366}
}
EUVIMED